CML therapeutic agents with reduced drug-resistance and side-effect comprising 1,6-disubstituted indole compounds

CML therapeutic agents with reduced drug-resistance and side-effect comprising 1,6-disubstituted indole compounds

The present invention relates to a therapeutic agent for chronic myelogenous leukemia with reduced drug-resistance and side-effects containing a 1,6-disubstituted indole compound.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Yoon, Ho Jong, Nam, Yun Ju, Hur, Woo Young, Choi, Hwan Geun, Sim, Tae Bo
Format: Patent
Sprache:eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention relates to a therapeutic agent for chronic myelogenous leukemia with reduced drug-resistance and side-effects containing a 1,6-disubstituted indole compound.